INQOVI Trademark

Trademark Overview


On Wednesday, February 12, 2020, a trademark application was filed for INQOVI with the United States Patent and Trademark Office. The USPTO has given the INQOVI trademark a serial number of 79282613. The federal status of this trademark filing is REGISTERED as of Tuesday, October 20, 2020. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The INQOVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating cancer; pharmaceutical preparations for treating immune disorders; pharmaceutical preparations for treating hematological disorders
inqovi

General Information


Serial Number79282613
Word MarkINQOVI
Filing DateWednesday, February 12, 2020
Status700 - REGISTERED
Status DateTuesday, October 20, 2020
Registration Number6177299
Registration DateTuesday, October 20, 2020
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements


Description of MarkThe mark consists of the stylized wording "INQOVI" with the letter "O" in black, green and orange and the remaining letters in black.
Goods and ServicesPharmaceutical preparations for treating cancer; pharmaceutical preparations for treating immune disorders; pharmaceutical preparations for treating hematological disorders
Indication of Colors claimedThe color(s) black, green and orange is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Tuesday, March 26, 2024CHANGE OF OWNER RECEIVED FROM IB
Monday, March 1, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, February 10, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 10, 2021FINAL DISPOSITION PROCESSED
Wednesday, January 20, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 20, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Friday, July 31, 2020NOTIFICATION PROCESSED BY IB
Wednesday, July 15, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 15, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 30, 2020ASSIGNED TO LIE
Monday, June 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, June 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, June 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 29, 2020REFUSAL PROCESSED BY IB
Thursday, May 14, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 14, 2020REFUSAL PROCESSED BY MPU
Saturday, May 2, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 1, 2020NON-FINAL ACTION WRITTEN
Thursday, April 30, 2020ASSIGNED TO EXAMINER
Friday, April 24, 2020APPLICATION FILING RECEIPT MAILED
Monday, April 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 14, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 9, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB